CLARIVATE Business Summary

Clarivate PLC (CLVT) is a global provider of transformative intelligence and analytics, operating primarily through a high-margin subscription model that accounts for approximately 97% of its revenue from proprietary solutions. The company organizes its operations into three core business segments: Academia & Government (A&G), which provides research and workflow software; Intellectual Property (IP), offering patent intelligence and maintenance services; and Life Sciences & Healthcare (LS&H), delivering data-driven insights for drug development and commercialization. Clarivate competes directly with diversified information giants such as RELX (Elsevier), Thomson Reuters, and Wolters Kluwer. Within this landscape, Clarivate differentiates itself by focusing exclusively on the end-to-end innovation lifecycle, leveraging curated data sets and AI-powered tools like the Nexus academic assistant to support high-stakes decision-making. Formed in 2016 through the $3.55 billion carve-out of Thomson Reuters' Intellectual Property and Science business by Onex Corporation and Baring Private Equity Asia, Clarivate is currently led by CEO Matti Shem Tov, who took the helm in August 2024 with over 30 years of experience in software and data analytics. The executive team includes CFO Jonathan Collins, formerly of Dana Incorporated and ProQuest, and CIO Bill Graff, who oversees the firm’s global technology infrastructure. The Board of Directors is chaired by Andrew Snyder, CEO of Cambridge Information Group, and includes prominent representatives from major institutional investors such as Usama Cortas of Leonard Green & Partners and Anthony Munk of Onex Corporation. Other notable shareholders and board-level influences include Exor NV and Impactive Capital, reflecting a strong pedigree of private equity and institutional backing.